medicines company (MDCO:NASDAQ GS)
Earnings & Estimates Summary - MEDICINES COMPANY (MDCO)
2012 revenues at The Medicines Company totaled $558.6M USD, while annual earnings equaled $1.91 per share.
Quarterly Earnings & Estimates - MEDICINES COMPANY (MDCO)
The Medicines Company's Quarterly Earnings
The Medicines Company reported 3rd quarter 2013 earnings of $0.47 per share on 10/25/2013.
Annual Earnings & Estimates - MEDICINES COMPANY (MDCO)
The Medicines Company's Annual Earnings
The Medicines Company reported annual 2012 earnings of $1.91 per share on 02/22/2013.
Quarterly Revenues - MEDICINES COMPANY (MDCO)
The Medicines Company's Quarterly Revenues
The Medicines Company had 3rd quarter 2013 revenues of $174.3M USD. This bettered the $173.7M USD consensus of the 10 analysts covering the company. This was 27.4% above the prior year's 3rd quarter results.
Annual Revenues - MEDICINES COMPANY (MDCO)
The Medicines Company's Annual Revenues
The Medicines Company had revenues for the full year 2012 of $558.6M USD. This was 15.2% above the prior year's results.
|Actelion Ltd||SFr.71.75 CHF||-0.75|
|Baxter International Inc||$66.70 USD||-0.07|
|Cornerstone Therapeutics Inc||$9.50 USD||0.00|
|Eli Lilly & Co||$49.96 USD||+0.09|
|Medicure Inc||C$0.22 CAD||0.00|
|View Industry Companies|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Boston, MA | TripAdvisor LLCPosted: Dec 05
- Asheville, NC | Mission HospitalsPosted: Dec 05